Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

Ambea increases profit, margins and free cash flow significantly in Q2 2026

Ambea reported an adjusted earnings per share of SEK 2.13 (+88%) and an adjusted EBITA of SEK 397m (+28%) for Q2 2026. The rolling 12-month EBITDA margin reached 10.0% and free cash flow rose to SEK 929m. Net sales grew by 7% (organic 4.4%), leverage fell to 2.4x EBITDA and the stock climbed close to a 52-week high. Management highlights a strong pipeline of over 2,200 new care places, continued bolt-on acquisitions and the scheduled takeover offer for Humana. » More on de.investing.com
Ambea increases Q3 revenue by 16% and improves margins through acquisitions

Ambea reports Q3 2025 net sales growth of 16%, driven by acquisitive growth of 13.2% and 3.5% organic growth. Adjusted EBITA rose 19% to 570 MSEK and the EBITA margin improved to 13.9%; adjusted diluted earnings per share for 12 months increased significantly to 10.38. The company is expanding its pipeline and entering Finland via the Validia acquisition (about 90 MSEK in annual net sales), reports strong free cash flow of 696 MSEK and has launched a share buyback program while giving a positive outlook. » More on de.investing.com
Ambea surpasses Q2 expectations and stock rises sharply after strong numbers

Ambea reports a 16.2% increase in net sales for Q2 2025, driven by organic growth and acquisitions including the purchase of Validia, and met all financial targets. EBITDA rose 15% and the share price jumped 9.04% after the announcement; management plans further growth through acquisitions and expansion of care places in Finland. Risks remain around the integration of Validia as well as the competitive and macroeconomic environment. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics

In 2026, Ambea AB has already paid €0.24 in dividends. The last payout was in May.

Financials

In the last quarter, Ambea AB had revenue of €395.87M and net profit of €15.43M

(EUR)	June 2026	YoY
Revenue	395.87M	7.90%
Gross profit	30.5M	91.39%
Net profit	15.43M	80.98%
EBITDA	30.5M	47.47%

Fundamentals

Metric	Value
Market capitalization	€1.4B
Number of shares	83.47M
52-week high/low	€17.57 - €10.21
Dividend yield	1.40%
Dividends TTM	€0.24
Beta	0.66
P/E ratio	19.33
PEG ratio	0.67
P/B ratio	2.88
P/S ratio	0.91

Company profile

Ambea AB (publ) provides housing, support, education, and personnel for health and social care for the elderly and people with disabilities in Sweden, Norway, and Denmark. The company operates through Nytida, Vardaga, Stendi, Altiden, and Klara segments. The Nytida segment comprises residential facilities, support for individuals and families, schools for children, young people and adults with disabilities or psychosocial problems, and day services. The Vardaga segment offers nursing homes, short-term residential facilities, home care, and day services for elderly people. The Stendi segment provides for children, young people, adults by offering personal assistance, residential care, elderly care, and home care. The Altiden segment comprises operations in elderly care, home care, social care, and disability care. The Klara segment offers subscription services for ambulatory care teams; and a supply of temporary doctors and nurses. Ambea AB (publ) was founded in 1996 and is headquartered in Solna, Sweden.

Name	Ambea AB
CEO	Mark Jensen
Headquarters	Solna, ab Sweden
Website	ambea.se
Sector	Health Care
Industry	Health Care Providers & Services
IPO	03/31/2017
Employees	41,000